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Detection of plasma proteins during sequential ultrafiltration/dialysis.
Elimination of low molecular weight proteins during sequential ultrafil-
tration/dialysis was studied in 29 uremic patients. Beta-2-microglobulin,
retinol binding protein, free light chains lambda and kappa, Zn-alpha-
2-glycoprotein, hemopexin, prealbumin, hemoglobin, albumin, acid
alpha-l-glycoprotein, haptoglobin, alpha-l-antichymotripsin, ribonu-
clease, lysozyme, amylase, non-specific esterase, and proteolitic activ-
ity were detected in all ultrafiltrates tested. The level of total protein
and ribonuclease was determined in 36 crude ultrafiltrates from 23
patients. Concentrated ultrafiltrates were used to quantitate retinal
binding protein, prealbumin, albumin, lysozyme, and amylase. Other
proteins identified in the ultrafiltrates are present in trace amounts. The
question was discussed whether inextensive but systematic loss of
proteins during hemofiltration in chronic RDT might be the cause of
patient homeostasis disturbances.
Detection des proteines plasmatiques paSsant dans l'ultraliltrat au
cours d'une ultraffltration!dlalyse séquentielle. L'élimination de
protéines de faible poids moléculaire au cours d'une ultrafiltration!
dialyse sdquentielle a ét6 6tudiée chez 29 malades urCmiques. La
beta-2-microglobuline, Ia protéine liant le rétinol, les chaines légCres
fibres lambda et kappa, Ia Zn-alpha-2-glycoprotéine, l'hemopexine, Ia
préalbumine, l'hemoglobine, l'albumine, l'alpha-l-glycoprotéine acide,
l'haptoglobine, l'alpha-l-antichymotripsine, Ia ribonucidase, Ic lyso-
zyme, l'amylase, l'estérase non specifique, et l'activité protéolytique
ont Cté ddtectées dans tous les ultrafiltrats testes. Le niveau de
protéines totales et de ribonuciCase a eté déterminC dans 36 ultrafiltrats
bruts provenant de 23 malades. Des ultrafiltrats concentrés ont été
utilisCs pour quantifier Ia protéine de liaison du rétinol, Ia préalbumine,
l'albumine, le lysozyme, et l'amyiase. Les autres protCines identifies
dans les ultrafiltrats sont prdsentes a l'état de traces. Nos résultats
suggerent qu'une perte non extensive, mais systematique de protéines
au cours de l'hCmofiltration lors de RDT chronique pourrait être Ia
cause d'altération de l'homéostasie des malades.
Almost 100,000 people all over the world live on repeated
dialysis treatment (RDT) [1]. Hemofiltration is the method of
choice in several dialysis centers [2—51. In this system, the loss
of the body fluids is replaced by equal volume of the modified
Ringer fluid. Transmembrane passage of plasma solutes de-
pends on the membrane permeability, the pressure difference at
the both sides of the membrane, and the blood flow rate. Today,
however, so-called sequential ultrafiltration/dialysis (SUD) is
becoming more and more popular [1, 6—8]. In this method,
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ultrafiltration follows dialysis without compensation of the lost
extracellular fluid.
Non-selectivity is the main drawback of both dialysis and
hemofiltration. Unfortunately, beneficial removal of uremic
substances from the body fluids is accompanied by depriving
the patient's body of many physiologically important middle
and low molecular weight substances, including proteins [9—11].
To date there is little information about which proteins are
filtrated through the dialyzing membrane during SUD [12].
According to the porosity of the cuprophane membrane, we
could expect that mainly low molecular weight proteins would
pass to the ultrafiltrate. As many of them play various important
roles, such as transport, enzymatic, inhibitory, and the like [13,
14], their systematic loss might influence the organism
homeostasis. The aim of our investigations was to estimate the
extent of this influence by detailed study of which plasma
proteins and in what amounts are filtrated through dialyzing
membrane during SUD.
Methods
We studied 29 patients with end-stage kidney insufficiency (7
female, 22 male, ages 20 to 56 years) treated with SUD. The
patients were dialyzed 15 to 18 hr weekly for 3 to 27 months
using Belco low ultrafiltration dialyzers Vita 2. Anemia was
observed in all tested patients (Ht 20 to 25%). The diet was
without restrictions (salt limit in individual cases). Hypotensive
drugs, aluminum hydroxide, and vitamins were given to the
patients during the therapy. None of the patients had blood
transfusions during the last 2 months. All of them were under
permanent outpatient unit control.
Ultrafiltrates were obtained by ultrafiltration from patients
overhydrated, suffering from hypertension resistant to drugs.
Every patient was dialyzed for 30 mm, then dialyzing fluid was
removed from dialyzer and transmembrane pressure raised up
to 200 to 250 mm Hg. Five-hundred to 800 ml of ultrafiltrate was
usually collected during 40 mm of hemofiltration.
Five ultrafiltrates from five patients were tested to find out
whether protein profile changes during ultrafiltration. Subse-
quent fractions were collected every 10 mm (fraction volume
about 100 ml).
To test the presence of individual proteins, each ultrafiltrate
was first partially desalted by dialyzing against water for 24 hr
using cellophane tubing (Viking Dialysing Tubing, Serva, Fed-
eral Republic of Germany), and then concentrated in the same
tubing in the stream of cold air (4°C). One- to two-hundredfold
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Fig. 1. Polyacrylamide gel electrophoresis of concentrated ultrafiltrate
(left, gel stained with 0.1% Coomassie BB R-250 in 26% C2H5OH with
5% formaldehyde; right, gel stained with 0.04% Coomassie BB G-250 in
3.5% HCIO4).
concentrated samples were finally desalted on Sephadex G-25
column equilibrated with distilled water. (Alternatively,
ultrafiltrates were diafiltrated and concentrated by the use of the
Amicon System, UM 05 membrane).
To determine the recovery of proteins in the ultrafiltrates
after concentration, the following experiments were performed
using sera from five patients treated by SUD: One ml of the
serum was diluted in 200 ml of physiological saline, dialyzed
against distilled water, and concentrated (about 20 and one- to
two-hundredfold, respectively) in the dialyzing tubing in the
stream of cold air (4°C).
The level of total protein, albumin, prealbumin, retinol-
binding protein, amylase, and lysozyme was determined before
diluting and after concentration.
The concentrations of total protein, ribonuclease, and beta-
2-microglobulin were high enough in crude ultrafiltrates to be
measured without these preliminary steps (desalting and
concentrating).
Electrophoresis in polyacrylamide gels performed both in
acid (pH 4.5) [15], and alkaline (pH 8.5) [16] pH was used for
protein separation. Gels were stained either by the use of
standard method (0.04% Coomassie brillant blue G-250 in 3.5%
HC1O4) or by the method of Steck [17] (0.1% Coomassie brillant
blue R-250 in 26% C2H5OH with 5% formaldehyde). The last
method retained all the proteins seen in the standard one and
additionally reveals low molecular weight and basic proteins
that were lost in the standard system (Fig. 1). Glycoproteins
were stained with Shiff's reagent. The localization of enzymes
in gels, with the exception of acid ribonuclease, was determined
according to Melnick [18]. Methods were adapted to polyacryl-
amide gel. Wilson's technique was followed to visualize the
pattern of acid RNase [19]: after electrophoresis, gels were
immersed in 0.4% solution of yeast RNA (Koch-Light, En-
gland), incubated for 2 hr in 37°C, stained with 0.2% toluidine
blue in 0.1% acetic acid buffered with NaOH to pH 3.0, and
then destained with the solvent. Sharp, transparent zones of
enzyme activity were seen, contrasting to the violet back-
Fig. 2. Polyacrylamide gel electrophoresis (pH 8.5) (left, crude (uncon-
centrated) ultrafiltrate; right, concentrated ultrafiltrate).
Fig. 3. Ouchterlony test for detection of individual proteins present in
concentrated ultrafiltrates. Starting from the upper row, left to right:
BMG, RBP, free light chains lambda, free light chains kappa, Zn-a2-Gp,
a1-Gp, Hpx, PA, A, a1-AC, and Hpt.
ground. The determination of lysozyme, ribonuclease, amylase,
and proteolitic activities were performed according to the
method of Schill and Schumacher [201. Samples were tested by
radial diffusion in 1% buffered agarose gel containing appropri-
ate substrate. (Standard deviations for lysozyme, ribonuclease,
and amylase are: 25.3 g/ml, 0.26 g/ml, 15.3 g/ml, and
coefficients of variation of reproducibility are 9.2, 10.2, and
6.9%, respectively).
Identification and quantitation of individual proteins were
made by: a) double immunodiffusion [21]; b) radial immunodif-
fusion in agarose gel [22]; and c) rocket and double dimension
electrophoresis [23, 24]. The total protein was determined by
the method of Lowry [25].
Results
Qualitative evaluation of plasma proteins was performed on
20 crude ultrafiltrates from 13 patients using polyacrylamide gel
electrophoresis, enzymatic and immunological tests. Polyacryl-
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Fig. 5. Polyacrylamide gel electrophoresis (pH 4.5) of concentrated
ultrafiltrate (left, gel stained with 0.1% Coomassie BB R-250 in 26%
C2H5OH with 5% formaldehyde; right, gel stained for RNase activity).
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amide gel electrophoresis of crude ultrafiltrates revealed 2 to 4
protein bands localized in the region of prealbumin, alpha and
beta globulins. One of these bands was immunologically iden-
tified as beta-2-tnicroglobulin (BMG). Crude ultrafiltrates exhib-
ited also ribonuclease (RNase) activity.
Plasma level of many low molecular weight proteins which
were expected to pass through the membrane varies from 0.02
x i0 to —1.4 x I0 g/liter. The methods we used, however
sensitive, have their detection limits. Generally, only proteins
of the concentrations exceeding 1 x iO g/liter may be
detected (except enzymes). To detect all, or almost all, the
proteins cleared to the ultrafiltrate, we repeated the procedure
of identification of proteins in 100 to 200 fold concentrated
material obtained from the same patients.
Six to ten protein bands were now clearly discernible. Com-
parative electrophoresis of crude and concentrated ultrafiltrates
is shown in Figure 2. Apart from BMG in concentrated
ultrafiltrates were detected: retinol-binding protein (RBP), free
light chains lambda and kappa, Zn-alpha-2-glycoprotein (zn-a2-
Gp), acid alpha- l-glycoprotein (a1-Gp), hemopexin (Hpx), albu-
mm (A), alpha-l-antichymotripsin (a1-AC), and haptoglobin
(Hpt) (Fig. 3).
Immunological identification of proteins by two dimensional
electrophoresis acrylamide-agarose is shown in Figure 4. As
can be seen, at least sixteen peaks are clearly discernible on the
immunoplate with human plasma proteins antiserum. Two of
the proteins tested (BMG and RBP) show heterogenity.
RNase (Fig. 5), amylase, lysozyme (LZ), non-specific ester-
ase and proteolitic activities were shown by all concentrated
ultrafiltrates.
The level of total protein and RNase was determined in 36
crude ultrafiltrates from 23 patients (Fig. 6, Table 1).
Table 2 illustrates the ratios of ultrafiltrate/plasma concentra-
tions of total protein and RNase.
Concentrated ultrafiltrates were used to quantitate RBP, PA,
A, LZ, and amylase (Fig. 7, Table 3). Other proteins identified
in the ultrafiltrates are present in trace amounts.
The results of the influence of dialysis and concentration on
the recovery of some plasma proteins are given in Table 4.
To find out whether the time of ultrafiltration influences
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Fig. 4. Two-dimensional (crossed) immunoelectrophoresis in acrylam-
ide-agarose system of the concentrated ultrafiltrate. Consecutive
agarose plates contain antisera to: A, plasma proteins; B, albumin; C,
BMG; D, prealbumin; E, RBP; and F, a1-Gp.
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Fig. 6. The level of total protein and RNase
Ribonuclease
in crude ultrafiltrates.
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Table I. Level of total protein and RNase in crude ultrafiltrates
Patient
Total
protein
mg/liter
Ribonuclease
mg/liter
X iO Patient
Total
protein
mg/liter
Ribonuclease
mg/liter
X I0
EK 117 Trace LF 432 240
SM 151 — W(J)G 439 296
MM 158 174 JT 440 266
Sw 213 90 LF 443 Trace
JP 284 316 JT 449 293
JP 289 174 W(1)G 450 250
SM 336 70 W(l)G 457 154
JT(r) 359 266 RG 460 260
WW 361 156 AS 486 266
LF 391 237 RG 490 270
wc 393 — LP 493 375
AG 403 374 LP 499 Trace
Sw 403 Trace AS(t) 529 407
AT 407 237 WG 539 624
BJ 411 — TS 553 316
JT 413 344 CA 592 374
AT 421 245 ZU 592 Trace
JT 430 370 JT(o) 645 206
Table 2. Ratios of ultrafiltrate/plasma concentrations of total protein
and RNase
Patient Total protein Ribonuclease
SM 2.3 lO —
WC 5.2 l0 —
JT 3.8 i0 0.1796
CA 2.7 10 0.3258
JP 2.6 lO 0.3189
JT(rz) 5.2 l0 0.2814
LF 4.5 iO 0.2260
JT(r) 5.4 iO 0.2684
wG 1.8 10 0.5848
EK 1.6 iO —
AT 4.2 l0 0.1936
TS 3.6 l0- 0.2403
Sw 3.6 iO 0.0840
W(1)G 4.9 l0- 0.2041
AG 4.1 10 0.3258
Fig. 7. Quantitation of selected protein parameters in concentrated ultrafiltrates.
porosity of the dialyzing membrane, the level of total protein,
BMG, and RNase was determined in subsequent fractions,
collected every 10 mm. Five patients were subjected to this
assay. Definitely lower levels of tested parameters were found
in the first fraction compared to subsequent ones (Fig. 8, Table
5).
The levels of following plasma components were determined
in sera of 15 patients, taken just before and at the end of the
ultrafiltration: a) total protein, RBP, alpha-1-Gp, PA; b) LZ,
RNase and amylase activity; and c) the ratios of the levels of
non-specific esterase (two substrates, alpha and beta naphtyl
acetate, were used). The results are shown in the Table 6.
Discussion
Many toxic substances are removed by diffusion through
semipermeable membranes in the course of dialysis. Molecules
with molecular weight below 500 daltons pass through the
membrane readily, middle molecules with molecular weights
from 500 to 15,000 daltons pass much less efficiently, and
proteins with molecular weight over 15,000 daltons are ex-
pected not to pass at all. During ultrafiltration, transmembrane
pressure is raised up to 200 to 250 mm Hg. In such conditions,
some proteins which, according to their molecular weights, are
to remain in blood vessels pass to the ultrafiltrate. We probably
are dealing with the effect of "squeezing" of proteins through
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Table 3. Quantitation of selected protein parameters in concentrated ultrafiltrates
Patient
Total
protein
mg/liter
Retinol-binding
protein Prealbumin Albumin Lysozyme Ribonuclease
mg/liter 1O mg/liter iO mg/liter iO mg/liter mg/liter IO
Amylase
U/liter 1O
ZU
LF
JT
JT
SM
WO)G
LF
RG
RG
AS
8
17
23
26
32
34
35
43
46
72
— Trace 12 — Trace
124 Trace Trace 0.07 2
63 27 60 0.91 12
78 18 260 0.99 12
— Trace Trace Trace 4
190 Trace 110 1.65 20
221 Trace Trace 0.66 26
778 Trace 230 Trace 33
326 1 120 1.60 37
302 Trace Trace 0.29 29
22
Trace
Trace
213
77
Trace
75
Trace
131
Trace
Table 4. Influence of dialysis and concentration on the recovery of some plasma proteins
Recovery, %
Concentration
ratioPatient
Total
protein
Retinol-binding
protein Prealbumin Albumin Lysozyme Amylase
MS
TJ
WW
NK
W(r)W
MS
TJ
WW
NK
W(r)W
73
85
83
82
65
50
74
64
70
58
94 98 78 a a
89 82 65 a a
77 85 68 a a
89 74 85 a a
64 72 72 a a
65 55 46 a 40
73 47 52 a 59
59 58 51 12 36
56 44 56 a 76
46 46 65 37 67
17
16
19
17
20
118
125
160
94
190
a Level below the range of the detection.
Table 5. Levels of total protein, BMG, and RNase determined in
consecutive ultrafiltrate fractions collected in 10-mm intervals
Patient
Fraction
mm
Total
protein
mg/liter
Ribonuclease
mg/liter
X 1O
Beta-2-microglobulin
diameter of immuno-
precipitate in mm
WG 0 to 10
10 to 20
20 to 30
30 to 40
237
382
478
512
32
73
110
136
6.4
7.2
8.2
8.7
LP 0 to 10
lOto2O
20 to 30
30 to 40
327
358
352
386
74
151
175
202
5.4
5.9
6.2
6.2
JT Oto 10
10 to 20
20 to 30
30to40
338
403
418
413
113
216
216
216
6.2
7.0
7.5
7.6
AS 0 to 10
10 to 20
20 to 30
30 to 40
505
550
587
565
45
96
96
103
7.7
8.1
8.2
8.5
WW 0 to 10
IOto2O
20to30
30 to 40
525
605
615
636
96
167
179
206
6.2
6.7
6.9
7.1
the semipermeable membrane, the nominal porosity of which
changes with the increase of the pressure.
The results of our investigations of the level of some proteins
in the fractions collected during consecutive 10-mm intervals of
the ultrafiltration support this view. Remarkable increases of
the level of total protein, BMG, and RNase were observed after
first 10 mm collection of the ultrafiltrate, being comparable in
the consecutive 3 fractions. It is reasonable to attribute this
phenomenon to the increase and then stabilization of membrane
permeability. Higher membrane porosity observed in this ex-
periment led us to study not only the loss of low molecular
weight proteins but also middle ones (Table 7), and we found in
the ultrafiltrates proteins such as: Zn-a2-Gp, a1-Gp, Hpx, PA,
A, a1-AC, Hpt, and amylase.
The reason for the absence of cs1-AT and Tf in the ultrafil-
trate, in spite of the presence of Hpt—a protein of higher
molecular weight, is unclear. Minute amounts of hemoglobin
detected in ultrafiltrate resulted probably from red blood cells
destroyed during dialysis.
The concentration process of ultrafiltrates deserves careful
attention. The performed experiment showed that the method
used in our work is satisfactory enough for high and middle
molecular weight proteins, but is less satisfactory for low
molecular ones.
The loss of middle molecular weight proteins during
hemofiltration is not extensive, but if systematic, in chronic
RDT might be the cause of body homeostasis disturbances and
might aggravate some clinical symptoms observed in uremic
patients [26—28].
One of the clinical disturbances observed in uremic patients
is anemia [27, 281. The loss of transport proteins such as Hpx
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Fig. 8. Levels of total protein, BMG, and RNase
determined in consecutive ultrafiltrate fractions
collected in JO-mm intervals. Symbols are: t,
Patient WG; A, LP; •, JT; 0, AG; 0, WW.
Table 6. Levels of some plasma components determined in sera of patients, taken just before and at the end of the ultrafiltration
Patient
Total
protein
g/liter
Retinol-binding
protein
g/liter JO—'
Acid alpha-I-
glycoprotein
mg/liter
Prealbumin
mg/liter
. 10' Lysozymeg/liter
Ribo-
nuclease
mg/liter
Amylase
U/liter
Non-specific esterase
beta- to alpha-
naphthyl esterase
SM 097.105 .224 '1.491 .704 076.9 .0.991 .252 .0.445
86.052 264 0.819 443 125.0 0.991 283 0.467
WC .94.737 .488 .1.890 '630 •67.0 01.235 .189 .0.514
84.473 456 2.541 748 116.6 1.235 212 0.516
JT 090.000 .344 01.533 0538 0101.5 01.147 .238 00.431
79.737 344 2.436 704 71.8 1.235 300 0.413
CA 088.200 .240 01.995 0584 088.4 01.148 0267 .0.426
92.100 240 1.806 554 217.6 1.148 267 0.423
JP 086,842 .224 .1 .302 0468 067.0 '0.991 0283 00.432
73.947 160 1.176 414 88.4 1.148 283 0.419
JT(rz) .83.421 .432 '1.806 .955 054.4 .1.315 0340 00.374
82.895 405 2.058 962 35.9 1,140 310 0.404
LF .81.579 0370 01 .638 0922 .27.2 01.062 0340 00.349
76.315 328 1.533 823 58.3 1.629 340 0.437
JT(r) 080.789 0440 .1.848 .517 067.0 '0.991 .168 '0.398
75.789 264 2.037 603 71.8 1.067 200 0.429
WG .80.526 0144 .0.630 0307 071.8 01.067 0252 00.412
88.421 144 1.050 386 82.5 0.921 267 0.410
EK 079.210 0128 .1.113 •363 '71.8 .0.991 .212 '0.439
81.315 176 1.596 422 94.7 1.235 212 0.449
AT 075.000 .312 '1.323 .519 .41.2 01.224 0340 '0.358
87. 105 297 2.016 731 35.8 0.988 373 0.378
TS 073.158 0266 '2.016 .540 038.4 .1.315 .296 .0.454
83.684 312 1.428 372 50.8 1.224 340 0.490
SW •72.632 .264 02.415 .500 094.7 01.067 0189 .0.445
65.789 264 3.486 653 108.8 1.067 212 0.442
W(1)G 071.316 0353 .1.911 0575 050.7 01.225 0246 00.537
65.526 237 1.659 550 44.2 1.061 310 0.585
AG .71,053 '296 01,386 .443 o82.5 '1.148 .336 00.507
84.474 256 2.184 620 108.8 1.540 336 0.459
• Before ultrafiltration.
and Hpt, which protect the Fe loss (Hpx by the hem binding,
Hpt by Hb binding), might be harmful.
The loss of albumin, which transports many low molecular
weight substances such as fatty acids, sex hormones, calcium,
some metals and pigments critical for normal function of the
organism, also cannot be ignored.
We cannot assess fully how detrimental is the loss of many
plasma proteins because their exact role is still unclear. For
example, consider a1-Gp. According to Hennksen's study [29],
it seems to be a co-factor for a lipolipase system of importance
for the hydrolysis of triglycerides. The loss of this protein
should be taken into consideration, as most of uremic patients
suffer from hypertriglyceridemia, one of the coronary heart
disease risk factors [26, 30].
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Table 7. Plasma proteins tested in the ultrafiltrates of the patients
treated with sequential ultrafiltration/dialysis
Protein
Molecular
weight
Range of usual plasma values
mg/dl
Beta-2-microglobulin 11,600 0.1 to 0.2
Retinol-binding protein 21,000 3.0 to 6.0
Lambda free light chains 23,000 Trace
Kappa free light chains 23,000 Trace
Zn-alpha-2-glycoprotein 41,000 2.0 to 15.0
Acid alpha-1-glycoprotein 44,000 55.0 to 140.0
Alpha-l-antitripsin 54,000 200.0 to 400.0
Hemopexin 60,000 50.0 to 115.0
Prealbumin 62,000 10.0 to 40.0
Hemoglobin 6-4,500
Albumin 66,248 3,500 to 5,500
Alpha-l-antichymotripsin 70,000 40.0 to 60.0
Transferrin 80,000 200.0 to 400.0
Haptoglobin 100,000 40.0 to 180.0
Ribonuclease 13,000 2.0 to 3.2 l0-
Lysozyme 15,000 0.5 to 1.5
Amylase 54,000 70.0 to 300 U/liter
Acid phosphatase 105,000 5.5 U/liter
Lactate dehydrogenase 135,000 70.0 to 300 U/liter
Non-specific esterase
Protease
Some proteins, especially of low molecular weight, are ex-
creted with urine or catabolized by the kidney. Renal failure
makes this process inefficient, leading to an increase of these
proteins levels in plasma [3l—33J, which can be the cause of
various clinical disturbances [28, 30, 34-36]. It cannot be ruled
out that the loss of some of low molecular weight proteins might
even be beneficial. We found that increased plasma level (5 to
10 times than normal) of low molecular weight proteins is
maintained in spite of dialysis therapy.
At present, no one can assess fully the meaning of the loss of
a particular protein during SUD on a patient's health. Never-
theless, we should be at least aware that such a process exists.
In our study, the average loss during ultrafiltration was 0.034
mg/mi compared to less than 0.03 mg/ml in normal glomerular
filtrate [371. It should, however, be kept in mind that most of the
protein that in the physiological state is reabsorbed from the
glomerular filtrate is irrevocably lost during ultrafiltration.
However, clinical implications of such a loss are not known, but
at present, they should not be ignored.
In conclusion, we would suggest the consideration of precise
monitoring of plasma protein loss during RDT, which might be
helpful in the selection of appropriate conditions such as
membranes and pressure for the individual patiennt.
Reprint requests to Dr. Z. Wichman, Protein Laborato,y, Depart-
ment of Biochemical Diagnostics, Nicolaus Copernicus Medical Acad-
emy, ul. Kopernika 17, 31-501 Krakow, Poland
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